Manning & Napier Group's INCY Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 92 shares of Incyte Corporation (INCY) worth $10,549, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 43 quarters.
Based on 13F filings since 2013, Manning & Napier Group has maintained a long-term strategic position in INCY, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2018, adding 2.41 M shares. Largest reduction occurred in Q4 2018, reducing 2.29 M shares.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's Incyte Corporation (INCY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Incyte Corporation (INCY) Trades by Manning & Napier Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +92 | New Buy | 92 | $114.66 |
| Q3 2021 | -20,879 | Sold Out | 20,879 | $84.10 |
| Q2 2021 | -479,102 | Reduce 95.82% | 20,879 | $84.10 |
| Q1 2021 | +28,458 | Add 6.04% | 499,981 | $81.27 |
| Q4 2020 | -1,986 | Reduce 0.42% | 471,523 | $86.98 |
| Q3 2020 | +3,591 | Add 0.76% | 473,509 | $89.74 |
| Q2 2020 | -35,870 | Reduce 7.09% | 469,918 | $103.97 |
| Q1 2020 | +4,825 | Add 0.96% | 505,788 | $73.23 |
| Q4 2019 | -24,368 | Reduce 4.64% | 500,963 | $87.32 |
| Q3 2019 | -301,367 | Reduce 36.45% | 525,331 | $74.23 |
| Q2 2019 | -775,146 | Reduce 48.39% | 826,698 | $84.96 |
| Q1 2019 | -722,429 | Reduce 31.08% | 1.6 M | $86.01 |
| Q4 2018 | -2.29 M | Reduce 49.64% | 2.32 M | $63.59 |
| Q3 2018 | +330,895 | Add 7.72% | 4.62 M | $69.08 |
| Q2 2018 | +2.41 M | Add 128.48% | 4.28 M | $67.00 |
| Q1 2018 | +716,584 | Add 61.85% | 1.88 M | $83.33 |
| Q4 2017 | +1.16 M | Add 0.00% | 1.16 M | $94.71 |
| Q3 2017 | +1.07 M | New Buy | 1.07 M | $116.74 |
| Q2 2017 | -55,375 | Sold Out | 0 | $0.00 |
| Q1 2017 | -36,595 | Reduce 39.79% | 55,375 | $133.63 |
| Q4 2016 | +91,970 | New Buy | 91,970 | $100.25 |
| Q1 2014 | -202,580 | Sold Out | 0 | $0.00 |
| Q4 2013 | -7,230 | Reduce 3.45% | 202,580 | $50.63 |
| Q3 2013 | -221,110 | Reduce 51.31% | 209,810 | $38.14 |
| Q2 2013 | +430,920 | Add 0.00% | 430,920 | $22.00 |
Manning & Napier Group's Incyte Corporation Investment FAQs
Manning & Napier Group first purchased Incyte Corporation (INCY) in Q2 2013, acquiring 430,920 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held Incyte Corporation (INCY) for 43 quarters since Q2 2013.
Manning & Napier Group's largest addition to Incyte Corporation (INCY) was in Q2 2018, adding 4,284,594 shares worth $287.07 M.
According to the latest 13F filing for Q2 2026, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 92 shares of Incyte Corporation (INCY), valued at approximately $10,549.
As of the Q2 2026 filing, Incyte Corporation (INCY) represents approximately 0.00% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings.
Manning & Napier Group's peak holding in Incyte Corporation (INCY) was 4,615,489 shares, as reported at the end of Q3 2018.